STAT | Reporting from the frontiers of health and medicine Follow STAT+: Sanofi shares drop after disappointing trial results Sanofi shares slid Thursday after the company reported underwhelming results from a closely watched trial in the skin condition atopic dermatitis. https://www.statnews.com/2025/09/04/sanofi-amlitelimab-immunology-atopic-dermatitis-eczema/ statnews.com
